- Novocure’s electric fields therapy fails key glioblastoma studyNovocure reported Thursday morning that its electric fields device combined with chemoradiation failed to extend glioblastoma patients' lives in a Phase 3 study, dampening the company's hopes of ex…Endpoints · 1mo ago↗ source
- How many Americans can afford high-quality health care? A new poll finds the number has fallenA new poll shows only about half of U.S. adults could afford their health care and had access to quality care last year.STAT · 1mo ago↗ source
- Innoviva revives Lyndra's long-acting oral drug platformA healthcare asset and royalties holding company is bringing a long-acting oral medicine approach back to life, resurrecting a drug delivery platform that had accumulated more than $380 million in…